Use of taurolidine to treat tumors
US7479505B2 · kind B2 · utility
2Cited by
27References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 2004 |
| Grant date | Jan 20, 2009 |
| Priority date | — |
| Expiry date | Nov 5, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method of inhibiting tumor growth in a mammal, by administering to the mammal composition containing taurolidine, taurultam, or a biologically active derivative thereof. The composition is administered to directly contact a tumor cell at a dose sufficient to induce cell death by apoptosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.